Mediterranean Diets: low-carb versus low glycemic load

Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss
Original source: Nutrition Journal 2008, 7:30
Authors: Joaquin Perez-Guisado (corresponding author), Andres Munoz-Serrano, and Angeles Alonso-Moraga
Publication date: 26 October 2008
DOI (digital document ID): 10.1186/1475-2891-7-30
Requires subscription? No
Publicly-available abstract: Yes

Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial
Original source: Nutrition & Metabolism 2008, 5:29
Authors: Robert H Lerman (corresponding author), Deanna M Minich, Gary Darland, Joseph J Lamb, Barbara Schiltz, John G Babish, Jeffrey S Bland, and Matthew L Tripp
Publication date: 4 November 2008
DOI (digital document ID): 10.1186/1743-7075-5-29
Requires subscription? No
Publicly-available abstract: Yes

Synopsis:
Both of these studies looked at variants of the Mediterranean Diet, followed over a period of 12 weeks (three months). The Spanish study emphasized the use of virgin olive oil as the primary source of dietary fat, green vegetables and salads as the primary source of carbohydrates, and fish as a primary source of protein. The US study is a follow-on to a previous study comparing a low-glycemic-load Mediterranean diet with added soy protein and phytosterols (plant-based fats) to the American Heart Association's diet plan. In this study, the diet is supplemented with plant-derived substances (phytochemicals) that they believe will improve insulin sensitivity and reduce cardiovascular and metabolic risk factors.

In the Spanish study, 31 obese people (BMI approximately 36) in their mid- to late-thirties were studied. They were not given caloric limits, but their diets included approximately 2 tablespoons of virgin olive oil (2 teaspoons per meal), 1-2 glasses wine daily (half at lunch and half at dinner),
green vegetables and salads to a maximum of 30 g carbohydrate per day, and unlimited protein. Non-nutritive sweeteners were allowed on this diet. Protein was divided into "fish" and "non-fish" (meat, fowl, eggs, shellfish and cheese), with "fish" and "non-fish" being consumed on separate days, and at least four "fish days" per week. In addition, subjects were allowed up to two cups of coffee or tea per day, and required to drink at least three liters of water per day. The subjects were given a standard multivitamin-and-mineral supplement and a calcium supplement; they were also asked to check their urine for ketones using ketostrips.

• Results: After 12 weeks, the subjects lost about 14 kg (30-35 lb), lowered their blood pressure (by about 15 points (millimeters mercury) systolic and 9 points diastolic), lowered their total cholesterol about 10%, significantly dropped their triglyceride levels (from about 218 down to 114 mg/dl), and reduced their fasting blood glucose level about 16 mg/dl. In addition, LDL ("bad") cholesterol levels dropped about 8%, and raised their HDL ("good") cholesterol about 9%. While the subjects were not heavy enough to have moved from "obese" to "overweight" in this time frame, the measured changes moved the patients' statuses from "prehypertension" to "normal blood pressure", from "prediabetic" to "normal", and from "high cholesterol" to "normal cholesterol". Based on the factors used to diagnose it, these subjects would be considered to no longer have metabolic syndrome. The researchers did not measure the beginning and ending percentages of body fat versus muscle mass, but their visual observation suggests that the weight lost was primarily fatty tissue.
• Limitations: The study had a number of limitations, including small size, short duration, highly-selected population, no measurement of total caloric intake, and the possibility that weight loss alone, as well as any of the factors of the program -- either by itself or in combination with others -- may have accounted for these changes. The authors suggest further study with a larger group of people, for a longer period of time, and also comparison with other low-carb diets.

The US researchers' initial viewpoint is that modern diets induce tissue inflammation, resulting in metabolic syndrome. They state that a number of active ingredients in medicinal plants target the pathways of this inflammation, and believe that the addition of these active agents to a low-glycemic-load adaptation of the Mediterranean diet can assist the body in repairing this damage. The US study included 49 patients with metabolic syndrome, average age 53 years, average BMI approximately 34. All subjects had high LDL cholesterol and triglycerides, and had at least two of the other signs used to diagnose metabolic syndrome (low HDL cholesterol, stage I hypertension or drug-treated hypertension, large waist size, and impaired fasting glucose. Half were put on a modified Mediterranean diet alone; the other half were put on the modified diet with the inclusion of phytochemical supplements. The two groups were split out in a way to minimize the initial differences between them.
In this version of the Mediterranean diet, wine was limited to 1 glass per day. Whole grains were allowed, but only one serving per day. Vegetables were mostly limited to very low glycemic load vegetables, with a maximum of one "occasional" serving of a small category of
phytochemical-rich vegetables with a moderate glycemic index (55-70). The only sweeteners allowed were stevia and low-glycemic agave nectar syrup.
The group receiving phytochemical supplementation received a nutritional supplement beverage (powdered) and supplement tablets. All subjects were required to engage in moderate aerobic exercise (at 70-75% target heart rate) for at least 2.5 hours per week. Food cravings, as well as food intake and satiety levels, were monitored (patient-generated logs and surveys). The results were analyzed, accounting for the effects of weight loss, consuming fewer calories, and consuming lower levels of carbohydrate.

• Results: At the end of 12 weeks, the diet-alone subjects lost about 5.7 kg (about 12.5 lb), and the supplemented group about an extra half-pound. While both groups showed lowered total cholesterol, LDL, and triglycerides, the group receiving the supplements saw greater reductions in these readings. Only the group with the supplements had increased HDL cholesterol. The group receiving the supplements were able to lower both systolic and diastolic blood pressure by about 6 points, while those receiving diet alone were only able to lower their systolic blood pressure, by about 4 points. Hemoglobin A1c (HbA1c), a measure of long-term blood glucose levels, went down in both groups, but fasting blood glucose did not drop in the group receiving supplements. Twice the number of subjects in the group receiving supplements were able to move from "having metabolic syndrome" to "normal".

Reliability:
The authors in the Spanish study are associated with the Genetics department of the University of Cordoba and do not report any conflicts of interest. Their bibliographic references are from peer-reviewed journals, mostly in the realm of nutrition.

The authors in the US study all work for the MetaProteomics, a research subsidiary of Metagenics, a company which produces and sells dietary plans, including a number of dietary supplements and meal replacement formulas, which it states will improve the health, weight,
and longevity of people with metabolic syndrome and cardiovascular disease. The MetaProteomics subsidiary is aimed at research into human proteins and how specific chemicals in foods are used by the human body. The bibliographic references are from peer-reviewed journals, and their source research is aimed more at finding the causes of cardiometabolic disease as well as specific chemicals that might lessen the probability of developing these diseases. As employees of a subsidiary of Metagenics, the authors' research is aimed at developing new products (both diets and supplements) for Metagenics to sell.

Both studies are limited in small sample size over short amounts of time; additionally, the Spanish study considers fewer variables.

There are significant differences in the two low-glycemic/low-carb "Mediterranean diets" studied: the Spanish study centers on healthy proteins and fats, while the US study aims more at trying to determine the effect of an anti-inflammatory diet and of the phytochemical
supplements the company sells.

Practical Applications:
Both versions of "Mediterranean diet", unsupplemented, showed favorable changes in cholesterol levels and blood glucose levels. The Spanish study showed greater changes in weight loss, blood pressure, triglycerides, and HDL cholesterol than the US study including supplements; however, the limitations of both studies does not indicate how effective either diet is at maintaining long-term health, or how safe they are over long periods of time.

Any highly-restrictive diet has its limitations, and even some less-restrictive diets may not be suitable for your personal medical conditions. Please consult your doctor and nutritionist before making any large-scale changes to your diet.

This synopsis and comparison was based on the full articles.

Metabolic syndrome increases risk of heart attack and stroke

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients
Original source: Journal of Human Hypertension (2008) 22, 358–365
Authors: A L M Vlek, Y van der Graaf, W Spiering, F L J Visseren (corresponding author), SMART study group
Publication date: published online 14 February 2008
DOI (digital document ID): doi:10.1038/jhh.2008.5
Requires subscription? Not for this article
Publicly-available abstract: Yes

Synopsis:
People with high blood pressure and vascular disease (diseases of the blood vessels) are at increased risk for recurrences of vascular disease, and for developing additional cardiovascular diseases such as heart disease, stroke, peripheral artery disease, and aneurysms. This study aims to find out whether having metabolic syndrome, and/or Type 2 diabetes, increases those risks even further.

Over 2000 people who were part of the Second Manifestations of Arterial Disease study (SMART) were followed for up to 10 years afterward for death, strokes, and heart attacks. These were used to calculate the risks of cardiovascular disease for people with high blood pressure only, for high blood pressure and metabolic syndrome, and for people with high blood pressure and diabetes.

Of this group, patients with metabolic syndrome (but without diabetes) had higher rates of stroke, heart attack, and sudden deaths related to cardiovascular issues. Patients with Type 2 diabetes had even higher risks than those with metabolic syndrome (but without diabetes). The increased risk of people with metabolic syndrome was not explainable by diabetes.

Further lowering of blood pressure did not seem to reduce the increased risk of heart attack and stroke in patients with metabolic syndrome.

Because people with metabolic syndrome have been shown to have higher risk of cardiovascular disease, investigators suggest more attention should be paid to diagnosing metabolic syndrome and treating it aggressively.

Reliability:
A large number of people were observed over a relatively long period of time. The authors work in a university medical center. The research was published in a peer-reviewed journal. The results should be relatively reliable.

Practical Applications:
Patients and healthcare providers should pay more attention to identifying the signs of metabolic syndrome and treating it with diet, exercise, and drugs (where appropriate).

Health insurance and life insurance actuaries will want to account for this relationship in their risk tables when determining coverage and premiums.

This synopsis was based on the entire article.